Background for Synta Pharmaceuticals (SNTA)

Posted on March 9th, 2007 by Brian

Basic Info

Website: http://www.syntapharma.com/
Stock symbol: SNTA
IPO date:2/6/07
Total shares outstanding:33.82M (5M offered at IPO)
Other reviews: Seeking Alpha

Drugs/Platforms

Drugs in trials:
STA-4783 starting Phase 3 trials for treatment of melastatic melanoma
STA-5326 in Phase 2 trials for the treatment of Rheumatoid Arthritus and CVID

Drugs in development:
STA-9090 a heat shock protein inhibitor for the treatment of cancer
STA-9584 a vascular disrupting agent for the treatment of cancer
CRAC Channel Inhibitor for potential treatment of graft-versus-host disease (GVHD), immune disorders, allergies, and asthma.

Financials

Income: Yeah right!
Cash on hand:62.9million (as of the end of 2005)
Burn Rate:68.9 million (for 2005)
These numbers are pre-IPO, we’ll get to the cash infusion from the IPO later.

Are their any numbers/info you’d like to see on this overview posts in the future?

Next up on babybiotechs.com: Syntana’s most promising drug, STA-4783.

Filed under: Synta Pharmaceuticals (SNTA)

« Investing in Small Biotechs Synta Pharmaceuticals (SNTA) - Part 2 - Melanomas and STA-4783 »

6 Responses to “Background for Synta Pharmaceuticals (SNTA)”

  1. Juliet Holsman, on September 26th, 2010 at 6:56 am Said:

    Greetings. I truly did some network surfriding and regained this web log. I made up one’s mind by way of this web log put up and it is genuinely incredible . I emphatically really enjoy your site. Perfectly , the ball of sending is in guarantee the very finest on this genuinely deserving though subject. I added it and i ‘m hunting ahead to your forthcoming site reports . I also noted that your web site has some splendid tying in completed to that. I will correct apart get hold of your rss feed to rest informed of any rescripts. Tremendous info you had justly here. Delight maintain revise on your terrific article. Thanks.

  2. Cheap Web Hosting Providers, on July 31st, 2011 at 12:04 pm Said:

    Thanks a lot for sharing this with all of us you actually know what you’re talking about! Bookmarked. Kindly also visit my site =). We could have a link exchange agreement between us!The Best Web Hosting

  3. free hosting, on July 31st, 2011 at 12:10 pm Said:

    Very good article ;)

  4. AnypeReAcyked, on October 26th, 2011 at 11:03 am Said:

    Cool site!
    http://masterseo.com.ua/ - seo

  5. Biostar Pharmaceuticals, Inc, on December 10th, 2011 at 1:38 pm Said:

    BSPM is currently followed by 2 analysts. Both give the stock a positive rating. The average price target is 8.07, which implies 1,222.13% upside from current price.

  6. Lawana Carranzo, on April 28th, 2012 at 4:34 pm Said:

    I don’t even know the way I ended up right here, but I assumed this submit was once great. I do not understand who you might be but definitely you’re going to a well-known blogger should you are not already. Cheers!

Leave a Reply